Jennifer Garner reacts to Once Upon a Farm's eye-popping IPO

Once Upon a Farm (ticker: OFRM) began trading on the NYSE on Feb. 6, opening at $21 per share, a 16% increase versus its IPO price. The company, founded by Cassandra Curtis and backed by co-founder and celebrity investor Jennifer Garner, has expanded from refrigerated baby food into a broader line of fresh children's foods and positions its mission on superior nutrition, clean ingredients and taste. The public listing and immediate pop signal investor appetite for branded, mission-driven consumer food companies, while continued founder involvement and supplier relationships (including Garner's family farm) support the growth narrative.

Analysis

Market structure: Once Upon a Farm's IPO (OFRM) crystallizes investor interest in refrigerated, clean-label kids’ food and immediately benefits temperature-controlled logistics (e.g., Americold COLD), specialty produce suppliers, and cold-fill packaging vendors; incumbents reliant on shelf-stable or private-label baby food face incremental share pressure. Pricing power will be mixed — premium shelf prices can sustain ~200–500bps higher gross margins if scale and direct-store-delivery reduce shrink, but national grocery chains can blunt pricing via promotions and slotting fees.

Risk assessment: Key tail risks are a food-safety recall, co-packer/cold-chain failure, or celebrity reputational hit that could erase >50% market cap; also expect material selling at the typical ~180-day lock-up expiry (around Aug 2026) that could create 20–40% down pressure. In the near term (days–weeks) expect >20% volatility; medium term (3–12 months) outcomes hinge on 1) distribution wins with top-10 retailers and 2) unit economics (CAC payback <18 months) showing path to positive EBITDA.

Trade implications: Tactical plays include a small, disciplined long in OFRM on non-frenzied pullbacks (buy-if <10% from IPO open $21) with a 20% stop, and a 6–12 month structural long in COLD (2–4% position) to capture cold-chain secular lift. Use call spreads on OFRM around earnings or lock-up expiry to cap downside while retaining upside; consider a relative-value pair (long OFRM, short HNST) to isolate brand execution vs sector beta.

Contrarian angles: The market may overvalue celebrity halo and underestimate capital intensity of refrigerated fresh food — EBITDA conversion typically lags revenue by 2–4 years in this category (see Honest Company/HNST parallels). Watch retailer slotting fee disclosures, co-packer concentration (top-3 co-packers >50% of capacity), and inventory turn metrics; a 10–20% mispricing could appear if OFRM fails to prove repeat purchase within 90 days post-listing.

Key Decisions for Investors

• Establish a tactical 1–2% long position in OFRM only on a pullback >10% from IPO open ($21 → buy if < $18.90) within the next 2–6 weeks; use a 20% stop-loss and reassess after first quarterly filing (due within ~45–90 days) focusing on gross margin and retail distribution wins.
• Initiate a 2–4% medium-term (6–12 month) long position in Americold (COLD) as a cold-chain infrastructure play to capture rising refrigerated food volumes; add incrementally if utilization >85% or management raises FY guidance, and use a 15% stop-loss.
• Execute a relative-value pair trade: long OFRM (1%) vs short The Honest Company (HNST) (0.8%) for 6–12 months to hedge sector beta and isolate execution; unwind if OFRM underperforms HNST by >25% or if OFRM reports CAC payback <18 months.
• If liquid, buy a 6-month OFRM call spread (buy nearer-term OTM call / sell higher OTM call) sized to risk ≤0.5% of portfolio to capture upside around lock-up expiry (~Aug 2026) or quarterly beats; if no options, replicate with a small outright position with tight risk controls.
• Reduce exposure by 10–20% to small/mid-cap natural-food manufacturers without proprietary cold-chain capability over the next 3 months; redeploy into cold-chain infrastructure (COLD) or scalable refrigerated brands that disclose repeat-purchase rates and gross margins.